Center for Pharmaceutical Development

药物开发中心

• 批准号: 0968972
• 负责人: Eric Munson
• 金额: $ 27.5万
• 依托单位: University of Kansas Center for Research Inc
• 依托单位国家: 美国
• 项目类别: Continuing Grant
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-02-01 至 2011-06-30
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=0968972&HistoricalAwards=false
• 关键词: Center; Pharmaceutical; Development

0968003 Georgia Tech; Andy Bommarius 0968972 University of Kansas; Eric Munson The purpose of this proposal is to start a new I/UCRC "Pharmaceutical Manufacturing and Formulation" (CPMF) with a focus on addressing current challenges in the pharmaceutical industry, and developing solutions towards more selective and robust manufacturing processes, more stable formulations, and better characterized and consistent products. The lead institution of the proposed Center is Georgia Tech with a site location at the University of Kansas. CPMF proposes to explore areas important to pharmaceutical manufacturing and improved formulations for pharmaceuticals. The Center plans to develop methods and technologies that will produce better pharmaceuticals, make them last longer, be more effective, and safer. By combining the efforts of Georgia Tech, Duquesne University and the University of Kansas, the PIs have proposed a number of potentially important projects that could significantly advance the applied knowledge necessary to make better pharmaceuticals. CPMF will allow pharmaceutical companies a lower cost approach to advancing risky research in a cooperative manner such that important manufacturing needs and innovations can be pursued with shared risk and mutual gain. CPMF has assembled a very strong group of researchers who are well-qualified to perform the research outlined in the proposal. The proposed Center will promote the rapid development of safe and efficacious drugs and drug formulations, and will identify potential problems with proposed drug formulations, with the potential of improving or even saving human lives. The Center plans to involve graduate students and post-doctoral associates in performing and presenting their research, thereby creating an opportunity for them to interact with counterparts from pharmaceutical and medical areas. Plans for dissemination of results are well thought out and audiences are appropriate. The proposed Center also plans to put emphasis on recruiting under-represented groups.

0968003 佐治亚理工学院；安迪·博马里斯 0968972 堪萨斯大学； Eric Munson 该提案的目的是启动一个新的 I/UCRC“药品制造和配方”(CPMF)，重点是解决制药行业当前的挑战，并开发解决方案，以实现更具选择性和稳健的制造工艺、更稳定的配方，以及更好的特性和一致性的产品。拟议中心的牵头机构是佐治亚理工学院，地点位于堪萨斯大学。 CPMF 提议探索对药品制造和改进药品配方重要的领域。该中心计划开发方法和技术，以生产更好的药物，使其使用寿命更长、更有效、更安全。通过佐治亚理工学院、杜肯大学和堪萨斯大学的共同努力，PI 提出了许多潜在的重要项目，这些项目可以显着推进制造更好的药物所需的应用知识。 CPMF 将使制药公司能够以更低成本的方式以合作的方式推进有风险的研究，从而可以在分担风险和互惠互利的情况下追求重要的制造需求和创新。 CPMF 组建了一支非常强大的研究人员团队，他们完全有资格执行提案中概述的研究。拟议的中心将促进安全有效的药物和药物制剂的快速开发，并将识别拟议药物制剂的潜在问题，有可能改善甚至拯救人类生命。该中心计划让研究生和博士后参与执行和展示他们的研究，从而为他们创造与制药和医学领域的同行互动的机会。结果传播计划经过深思熟虑，受众也合适。拟议的中心还计划重点招募代表性不足的群体。